Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kokoh Exa Nusantara Tbk (KOCI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kokoh Exa Nusantara TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kokoh Exa Nusantara Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kokoh Exa Nusantara Tbk trades at Rp101 (market cap 451.21B, 14.06M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Kokoh Exa Nusantara Tbk is far larger — about 2.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Kokoh Exa Nusantara Tbk is more actively traded (14.06M versus 96.7K). Which is the better fit depends on your goals.

KOCIOBAT
Market Cap
451.21B167.37B
Volume
14.06M96.7K
Lot
140.63K967
Turnover
1.41B23.82M
Average Price
100.56246.34
Value
1.41B23.82M
Indicative Equilibrium Price
101248
Indicative Equilibrium Volume
1.94K41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KOCI
View details
OBAT
View details

About Kokoh Exa Nusantara Tbk

PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.

Read more on KOCI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT